http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105769837-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 |
filingDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105769837-B |
titleOfInvention | Aurantiamide Acetate from Stems is preparing the application in treating anti-malarial drug |
abstract | The present invention provides Aurantiamide Acetate from Stems to prepare the application in treating anti-malarial drug, and the structural formula of Aurantiamide Acetate from Stems is as follows: And provide the pharmaceutical composition that containing the Aurantiamide Acetate from Stems and pharmaceutically acceptable carrier forms.Weight content of the active constituent Aurantiamide Acetate from Stems in pharmaceutical composition is 5 95%.It is measured by external antimalarial active, the results show that Aurantiamide Acetate from Stems has preferable external antiplasmodial activities.Therefore, the drug of malaria is treated available for preparing, there is larger clinical value. |
priorityDate | 2016-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.